Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standalone Thoracoscopic Left Atrial Appendage Closure Versus Medical Therapy in Atrial Fibrillation

NCT07705282 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT07705282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07705282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standalone Thoracoscopic Left Atrial Appendage Closure Versus Medical Therapy in Atrial Fibrillation
Lead sponsor
Region Skane
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2028
Completion date
December 31, 2032
Enrollment
936 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial appendage closure for atrial fibrillation, oral anticoagulation, thoracotomy